✦ LIBER ✦

303Patients with asymptomatic prostate cancer T.0-4 N.0-2 M.0 not suitable for local definitive treatment: Do they need immediate androgen deprivation?

✍ Scribed by U.E. Studer; P. Whelan; W. Albrecht; J. Casselman; T. De Reijke; D. Hauri; W. Loidl; S. Isorna; S.K. Sundaram; M. Debois; L. Collette

Book ID: 118646436
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 206 KB
Volume: 4
Category: Article
ISSN: 1569-9056
DOI: 10.1016/s1569-9056(05)80311-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

WHICH PATIENTS WITH T0-4 N0 M0 PROSTATE

WHICH PATIENTS WITH T0-4 N0 M0 PROSTATE CANCER NOT SUITABLE FOR LOCAL TREATMENT WITH CURATIVE INTENT DO NOT NEED IMMEDIATE TREATMENT IN EORTC TRIAL 30891?

✍ L. Collette; U.E. Studer; P. Whelan; W. Albrecht; J. Casselman; T.M. De Reijke; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Using PSA to Guide Timing of Androgen De

Using PSA to Guide Timing of Androgen Deprivation in Patients with T0–4 N0–2 M0 Prostate Cancer not Suitable for Local Curative Treatment (EORTC 30891)

✍ Urs E. Studer; Laurence Collette; Peter Whelan; Walter Albrecht; Jacques Casselm 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 757 KB

IS THE DEGREE OF PSA DECLINE AFTER IMMED

IS THE DEGREE OF PSA DECLINE AFTER IMMEDIATE ANDROGEN DEPRIVATION A PROGNOSTIC FACTOR FOR OUTCOME IN PATIENTS WITH T0-4 N0 M0 PROSTATE CANCER NOT SUITABLE FOR LOCAL TREATMENT WITH CURATIVE INTENT? (RESULTS FROM THE EORTC 30891 TRIAL)

✍ Collette, L.; Studer, U.E.; Whelan, P.; Albrecht, W.; Casselman, J.; De Reijke, 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 53 KB

354 LONG TERM RESULTS OF IMMEDIATE VERSU

354 LONG TERM RESULTS OF IMMEDIATE VERSUS DEFERRED ANDROGEN DEPRI-VATION IN PATIENTS WITH NO LOCAL TREATMENT FOR T0–4 N0–2 M0 PROSTATE CANCER (EORTC 30891)

✍ Studer, Urs; Whelan, Peter; Albrecht, Walter; Wimpissinger, Florian; Casselman, 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 176 KB

PSA DOUBLING TIME AS PREDICTOR OF OBJECT

PSA DOUBLING TIME AS PREDICTOR OF OBJECTIVE PROGRESSION AND DEATH IN PATIENTS WITH T0-4 N0-2 M0 PROSTATE CANCER NOT SUITABLE FOR LOCAL DEFINITIVE TREATMENT ON WATCHFUL WAITING (EORTC 30891)

✍ L. Collette; U.E. Studer; P. Whelan; W. Albrecht; J. Casselman; T.M. De Reijke; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Re: Urs E. Studer, Laurence Collette, Pe

Re: Urs E. Studer, Laurence Collette, Peter Whelan, et al. Using PSA to Guide Timing of Androgen Deprivation in Patients with T0–4 N0–2 M0 Prostate Cancer not Suitable for Local Curative Treatment (EORTC 30891). Eur Urol 2008;53:941–9

✍ Narasimhan Ragavan; Paras B. Singh; Francis L. Martin; Andrew D. Baird 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 68 KB